Skip to main content
. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615

Table 1. Patient characteristics.

Engage N = 1405 Ensure N = 389 Trust N = 639 Total N = 2433
Age (years), mean (SD) 31.5 (3.3) 31.0 (3.1) 32.9 (3.6) 31.8 (3.4)
BMI (kg/m2), mean (SD)a 24.8 (2.7) 20.6 (1.5) 24.2 (2.4) 24 (2.9)
AFC, mean (SD)b 12.4 (4.5) 11.1 (4.4) 10.8 (4.7) 11.8 (4.6)
Dose reductions of rFSH from day 8 onwards, %c 46.1 37.1 90.3 56.7
Oocytes retrieved, mean (SD) 13.5 (7.4) 12.4 (6.9) 12.3 (7.0) 13.0 (7.2)
Fertility characteristics
Primary infertility, % 53.0 61.4 57.0 55.4
Duration of infertility (years), mean (SD)d 3.3 (2.4) 3.2 (2.2) 3.7 (2.9) 3.4 (2.5)
Dose of hCG administerede
10,000 IU, % 83.2 83.8 66.4 78.8
5000 IU, % 16.8 16.2 8.8 14.6
rhCG 250 μg, % 0.0 0.0 24.9 6.5
Day of hCG
Follicles ≥11 mm, mean (SD) 14.9 (6.6) 14.2 (6.4) 14.5 (6.5) 14.7 (6.5)
Serum E2, pmol/L, mean (SD) 5323.1 (3241.4) 5222.7 (3272.9) 5595.0 (3393.0) 5378.5 (3288.3)
Serum FSH, IU/L, mean (SD) 12.1 (3.1) 11.6 (3.0) 13.6 (3.7) 12.4 (3.3)
Serum LH, IU/L, mean (SD) 1.6 (1.7) 1.5 (1.7) 1.5 (1.9) 1.6 (1.8)
Serum P, nmol/L, mean (SD) 3.1 (1.8) 2.5 (1.5) 4.1 (23.4) 3.3 (12.1)

a6 missing body mass index (BMI) values;

b64 missing antral follicle count (AFC);

cbased on 2129 patients receiving rFSH from day 8 onwards;

d2 missing durations;

e3 other.